JBCHEPHARM Financial Statements

JBCHEPHARM Nine Monthly Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2018
Growth matrix (%)        
Revenue growth 18.70 15.10 26 4.81
Op profit growth (3) 48.40 73.30 (6.30)
EBIT growth (16) 66.90 83.30 (16)
Net profit growth (14) 64.70 96.60 (25)
Profitability ratios (%)        
OPM 22.40 27.40 21.30 15.50
EBIT margin 21 29.60 20.40 14
Net profit margin 15.90 21.90 15.30 9.82
RoCE 24.40 34.90 23.50 13.10
RoNW 4.89 6.90 4.73 2.47
RoA 4.61 6.47 4.42 2.29
Per share ratios ()        
EPS 50 58 35.30 16.60
Dividend per share 16.50 16.50 11 2
Cash EPS 40.50 49.10 26.60 9.74
Book value per share 276 234 186 172
Valuation ratios        
P/E 31.50 21.60 14.40 18.60
P/CEPS 38.90 25.50 19.10 31.80
P/B 5.70 5.35 2.74 1.79
EV/EBIDTA 20.90 14.40 9.17 10.20
Payout (%)        
Dividend payout -- -- -- 12.10
Tax payout (24) (25) (21) (28)
Liquidity ratios        
Debtor days 71.10 65.60 66.40 73.40
Inventory days 57 55.60 50.20 53.60
Creditor days (41) (46) (38) (35)
Leverage ratios        
Interest coverage (100) (83) (119) (57)
Net debt / equity -- 0.01 -- --
Net debt / op. profit -- 0.03 -- --
Cost breakup ()        
Material costs (35) (34) (36) (38)
Employee costs (18) (17) (18) (18)
Other costs (25) (22) (25) (29)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Revenue 2,424 2,043 1,775 1,409
yoy growth (%) 18.70 15.10 26 4.81
Raw materials (843) (701) (631) (538)
As % of sales 34.80 34.30 35.50 38.20
Employee costs (439) (341) (323) (251)
As % of sales 18.10 16.70 18.20 17.80
Other costs (599) (440) (443) (402)
As % of sales 24.70 21.50 25 28.50
Operating profit 543 560 378 218
OPM 22.40 27.40 21.30 15.50
Depreciation (73) (69) (66) (57)
Interest expense (5.10) (7.20) (3) (3.50)
Other income 39.20 112 50.70 36.60
Profit before tax 505 597 359 194
Taxes (119) (148) (77) (55)
Tax rate (24) (25) (21) (28)
Minorities and other (0.70) (0.60) (0.30) (0.40)
Adj. profit 385 448 282 138
Exceptional items -- -- (10) --
Net profit 385 448 272 138
yoy growth (%) (14) 64.70 96.60 (25)
NPM 15.90 21.90 15.30 9.82
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Profit before tax 505 597 359 194
Depreciation (73) (69) (66) (57)
Tax paid (119) (148) (77) (55)
Working capital 400 145 103 118
Other operating items -- -- -- --
Operating cashflow 714 525 319 200
Capital expenditure 1,456 726 640 513
Free cash flow 2,170 1,251 959 713
Equity raised 2,407 2,298 2,150 2,329
Investments (72) 376 5.60 (66)
Debt financing/disposal (31) 62.90 12.50 4.89
Dividends paid -- -- -- 16.70
Other items -- -- -- --
Net in cash 4,472 3,987 3,127 2,997
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2019
Equity capital 15.50 15.50 15.50 16.10
Preference capital -- -- -- --
Reserves 2,119 1,794 1,420 1,464
Net worth 2,134 1,810 1,435 1,480
Minority interest
Debt 54.60 45 29.50 25.80
Deferred tax liabilities (net) 60.30 72.10 64.10 77.20
Total liabilities 2,253 1,931 1,532 1,586
Fixed assets 1,296 659 667 636
Intangible assets
Investments 12.70 678 403 457
Deferred tax asset (net) 19.20 22.30 16 20.30
Net working capital 867 540 414 436
Inventories 410 347 275 244
Inventory Days 61.70 62.10 56.50 --
Sundry debtors 556 389 345 308
Debtor days 83.70 69.50 71 --
Other current assets 268 127 92.20 111
Sundry creditors (228) (194) (176) (119)
Creditor days 34.30 34.70 36.20 --
Other current liabilities (139) (129) (123) (107)
Cash 58.50 30.90 31 36.80
Total assets 2,253 1,931 1,532 1,586
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Dec-2021 Dec-2020 Dec-2019 Dec-2018 -
Gross Sales 1,800 1,514 1,331 1,224 --
Excise Duty -- -- -- -- --
Net Sales 1,800 1,514 1,331 1,224 --
Other Operating Income -- -- -- -- --
Other Income 37.20 87 47.50 25.80 --
Total Income 1,837 1,601 1,379 1,250 --
Total Expenditure ** 1,381 1,078 1,045 984 --
PBIDT 456 524 333 266 --
Interest 3.51 6.55 2.53 3.34 --
PBDT 452 517 331 263 --
Depreciation 50.60 52.10 48.90 44 --
Minority Interest Before NP -- -- -- -- --
Tax 96.10 112 65.30 71.50 --
Deferred Tax 4.49 4.92 (5.80) -- --
Reported Profit After Tax 301 348 222 147 --
Minority Interest After NP 0.55 0.36 0.41 0.37 --
Net Profit after Minority Interest 301 347 222 147 --
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 301 347 222 147 --
EPS (Unit Curr.) 38.90 45 27.70 17.90 --
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) 425 425 -- -- --
Equity 15.50 15.50 16.10 16.10 --
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 25.30 34.60 25 21.70 --
PBDTM(%) 25.10 34.10 24.90 21.50 --
PATM(%) 16.70 23 16.70 12 --
Open ZERO Brokerage Demat Account
Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity